Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pa...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: (954) 330-0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

stockanalyzer777 Dec. 13 at 12:14 AM

$SBFM

0 · Reply

Pomacanthus Dec. 12 at 10:38 PM

$SBFM just a reminder my prediction was 1:25 sometime next week…barely compliant & as per usual EOY. Stockanalyzer does your crystal ball still read $7 SP? curious

0 · Reply

Kalini67 Dec. 12 at 9:48 PM

$SBFM One of this days nobody will talking crap about this stock, it will Jump without News, is about time

0 · Reply

Masterrunner Dec. 12 at 9:34 PM

$SBFM It’s Christmas, Grinch. Facts don’t stop being facts.

0 · Reply

JB197519 Dec. 12 at 7:41 PM

$SBFM So, the bears are jacking off at ‘being right’. Oh the sugar rush of righteousness! But, how right? Right to invest in 2021? Right to keep holding and ploughing in funds when the company had no money (I think they call that the sunk cost fallacy). As I’ve always said, make your own mind up, do your own DD and, most of all, be happy and move on when you fuck up.

0 · Reply

Masterrunner Dec. 12 at 6:43 PM

$SBFM IMO , take this for what it’s worth: one morning they’ll run a hard pump off a low-effort, BS PR. That’s your exit window. After that, the current holders will be replaced by a fresh batch of “new and improved” bagholders who won’t care about what management did or how we got here. You’ll see the usual comments: “You invested too early, sorry for your loss.” How will you know it’s coming? Same signal as always; random pumpers start showing up the day before. That’s been their only consistent play. GLTA and enjoy the weekend.

1 · Reply

Pomacanthus Dec. 12 at 6:30 PM

$SBFM we tried to warn all you over zealous newbies, same ol same ol.

2 · Reply

Roosterscanfly Dec. 12 at 4:06 PM

$KITT $SBFM $SMX $SNAP $VS

0 · Reply

Nuisance Dec. 12 at 3:56 PM

$SBFM so nothing?

0 · Reply

Masterrunner Dec. 12 at 3:36 AM

$SBFM How did the annual investor's 5min coffee break go? Probably exactly how I told you it would go! People just don't listen ✌️

0 · Reply

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025, 7:45 AM EDT - 6 weeks ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 20, 2025, 7:45 AM EDT - 7 weeks ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 16, 2025, 7:45 AM EDT - 2 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 2 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 2 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 7:00 AM EDT - 2 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 9, 2025, 8:00 AM EDT - 2 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Jul 2, 2025, 8:00 AM EDT - 5 months ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025, 8:30 AM EDT - 6 months ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 7 months ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025, 8:30 AM EDT - 7 months ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025, 8:30 AM EDT - 8 months ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 9 months ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 9 months ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 11:35 AM EDT - 9 months ago

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug

Apr 2, 2025, 8:00 AM EDT - 9 months ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025, 5:09 PM EDT - 9 months ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025, 8:00 AM EDT - 9 months ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025, 9:00 AM EDT - 9 months ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 11 months ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 11 months ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 1 year ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 1 year ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sep 21, 2023, 9:05 PM EDT - 2 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Aug 11, 2023, 8:30 AM EDT - 2 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

May 16, 2023, 2:15 PM EDT - 2 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 9:58 AM EDT - 2 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 11, 2023, 9:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

Apr 5, 2023, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

Feb 28, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Feb 10, 2023, 7:35 AM EST - 3 years ago

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

Jan 19, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Announces Share Repurchase Program

Dec 20, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma's Annual Letter to Shareholders

Dec 5, 2022, 5:46 PM EST - 3 years ago

4 Stocks Meeting GuruFocus' Value Screens in December

RM CACC WFG

Nov 16, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

stockanalyzer777 Dec. 13 at 12:14 AM

$SBFM

0 · Reply

Pomacanthus Dec. 12 at 10:38 PM

$SBFM just a reminder my prediction was 1:25 sometime next week…barely compliant & as per usual EOY. Stockanalyzer does your crystal ball still read $7 SP? curious

0 · Reply

Kalini67 Dec. 12 at 9:48 PM

$SBFM One of this days nobody will talking crap about this stock, it will Jump without News, is about time

0 · Reply

Masterrunner Dec. 12 at 9:34 PM

$SBFM It’s Christmas, Grinch. Facts don’t stop being facts.

0 · Reply

JB197519 Dec. 12 at 7:41 PM

0 · Reply

Masterrunner Dec. 12 at 6:43 PM

1 · Reply

Pomacanthus Dec. 12 at 6:30 PM

$SBFM we tried to warn all you over zealous newbies, same ol same ol.

2 · Reply

Roosterscanfly Dec. 12 at 4:06 PM

$KITT $SBFM $SMX $SNAP $VS

0 · Reply

Nuisance Dec. 12 at 3:56 PM

$SBFM so nothing?

0 · Reply

Masterrunner Dec. 12 at 3:36 AM

$SBFM How did the annual investor's 5min coffee break go? Probably exactly how I told you it would go! People just don't listen ✌️

0 · Reply

Mmpt Dec. 12 at 12:31 AM

$SBFM Last year was exactly the same. This company doesn't prioritize the disclosure of studies, future expectations, or expansion plans. The consolidation of authorization to produce medicines is good, but it has costs in infrastructure, human resources, and marketing. I believe in the company's profit from the sale of generics. As for studies and trials, they will take much longer. The company has a future, but at the moment I believe that expanding the market to the US was essential.

1 · Reply

MB66 Dec. 11 at 4:12 PM

$SBFM been sending my questions (for a while now) to the good doctor, directly. No response of course, but you never know… mailto:[email protected]

1 · Reply

RonRon1234 Dec. 11 at 3:40 PM

$SBFM waiting for a pump and I'm out of this garbage stock. Usually I'm more positive...

1 · Reply

MB66 Dec. 11 at 3:18 PM

$SBFM aside from the usual, Slilaty approving all Proposals on the agenda with his preferred share Dictator powers, was there anything else discussed in the meeting?

1 · Reply

MB66 Dec. 11 at 3:13 PM

$SBFM wtf….. I was logged in, but no audio and I tried to submit my question, but the window to submit questions claimed that I had special characters in my question, and I was unable to submit my question. I did not have any special characters in my question. 🤬 Then all of a sudden, the meeting was over. I never heard anything. Ugh!

2 · Reply

Kalini67 Dec. 11 at 3:11 PM

$SBFM WTH only my question

0 · Reply

Kalini67 Dec. 11 at 2:50 PM

$SBFM Am in , my question is how the Company can help with the stock price and prevent manipulation

1 · Reply

Kalini67 Dec. 11 at 1:44 PM

$SBFM Surprise me Please

0 · Reply

stockanalyzer777 Dec. 11 at 1:10 AM

$SBFM The investors meeting is scheduled for tomorrow at 10 AM. Please find the access link below. A control number is required to join; however, I was not provided with one. I’ll try to log in using the link, but if I’m unable to join, could someone please record the meeting and share it here, or provide an update on the key points discussed? Additionally, if I cannot access the meeting, I’d appreciate it if someone could ask the questions on my behalf. I’m hopeful we will hear significant development news tomorrow—really hoping for strong momentum in the stock. The link to the meeting: https://east.virtualshareholdermeeting.com/vsm/web?pvskey=SBFM2025 Here’s a YouTube video showing how SBFM jumped 300–400% when they introduced their mRNA research project back in 2021-2022. https://www.youtube.com/watch?v=SscJBlDESBo

1 · Reply

Kalini67 Dec. 10 at 11:58 PM

$SBFM Got it

0 · Reply

Kalini67 Dec. 10 at 11:37 PM

$SBFM On December 5th the trading for SBFMW were halted because of pending news but nothing has been publicicly said

3 · Reply

contra7 Dec. 10 at 9:31 PM

$SBFM 18.4K on the bid @$1.43 since yesterday afternoon. MM games being played.

0 · Reply

Market Cap	6.57M
Revenue (ttm)	34.87M
Net Income (ttm)	-5.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-14.71%
Debt to Equity Ratio	0.00

Volume	67,700
Avg Vol	938,454
Day's Range	N/A - N/A
Shares Out	4.91M
Stochastic %K	0%
Beta	1.52
Analysts	Strong Sell
Price Target	$7.00